Abstract
Purpose
To compare the efficacy of the fixed combination of brimonidine–timolol (FCBT) and the fixed combination of brinzolamide–timolol (FCBZT) treatments for elevated intraocular pressure (IOP) after phacoemulsification cataract surgery.
Methods
A randomised, prospective, double-blinded study was conducted on 277 eyes of 257 patients who underwent phacoemulsification cataract surgery. Patients were divided into three groups based on the medication administered after cataract surgery as follows: FCBT, FCBZT and a control group where no antiglaucoma medications were used. IOP was recorded at preoperative and postoperative hours 6 and 24 and days 3 and 5.
Results
No statistical differences were observed among the groups regarding age, sex and baseline IOP levels (p > 0.05). Mean IOP levels were significantly lower in the treatment groups than in the control group at postoperative hours 6 and 24 and days 3 and 5 (p < 0.001). Administration of one drop of FCBT or FCBZT demonstrated similar effects on preventing IOP spikes within 24 h of phacoemulsification cataract surgery. FCBZT more effectively lowered IOP than FCBT at days 3 and 5 (p < 0.05).
Conclusions
We demonstrate that the postoperative administration of FCBT or FCBZT is effective in lowering IOP after phacoemulsification cataract surgery; FCBZT more effectively lowered IOP than FCBT at postoperative days 3 and 5.
Similar content being viewed by others
References
Kim J, Jo M-W, Brauner S, Ferrufino-Ponce Z, Ali R, Cremers S et al (2011) Increased intraocular pressure on the first postoperative day following resident-performed cataract surgery. Eye 25:929–936
Shingleton BJ, Wadhwani RA, O’Donoghue MV, Baylus S, Hoey H (2001) Evaluation of intraocular pressure in the immediate period after phacoemulsification. J Cataract Refract Surg 27(4):524–527
Shrivastava A, Singh K (2010) The effect of cataract extraction on intraocular pressure. Curr Opin Ophthalmol 21(2):118–122
Pohjalainen T, Vesti E, Uusitalo RJ, Laatikainen L (2001) Phacoemulsification and intraocular lens implantation in eyes with open-angle glaucoma. Acta Ophthalmol Scand 79(3):313–316
O’Brien PD, Ho SL, Fitzpatrick P, Power W (2007) Risk factors for a postoperative intraocular pressure spike after phacoemulsification. Can J Ophthalmol 42(1):51–55
Bömer TG, Lagrèze WD, Funk J (1995) Intraocular pressure rise after phacoemulsification with posterior chamber lens implantation: effect of prophylactic medication, wound closure, and surgeon’s experience. Br J Ophthalmol 79(9):809–813
Hayreh SS (2009) Ischemic optic neuropathy. Prog Retin Eye Res 28(1):34–62
Mansberger SL, Gordon MO, Jampel H, Bhorade A, Brandt JD, Wilson B et al (2012) Reduction in intraocular pressure after cataract extraction: the ocular hypertension treatment study. Ophthalmology 119(9):1826–1831
Wedrich A, Menapace R (1992) Intraocular pressure following small-incision cataract surgery and polyHEMA posterior chamber lens implantation: a comparison between acetylcholine and carbachol. J Cataract Refract Surg 18(5):500–505
Hollands RH, Drance SM, House PH, Schulzer M (1990) Control of intraocular pressure after cataract extraction. Can J Ophthalmol 25(3):128–132
Dayanir V, Özcura F, Kir E, Topaloglu A, Özkan SB, Aktunç T (2005) Medical control of intraocular pressure after phacoemulsification. J Cataract Refract Surg 31(3):484–488
Georgakpoulus CD, Makri OE, Plotas P, Pharmakakis N (2013) Brinzolamide–timolol fixed combination for the prevention of intraocular pressure elevation after phacoemulsification. Clin Exp Ophtalmol 41(7):662–667
Kasetti SR, Desai SP, Sivakumar S, Sunderraj P (2002) Preventing intraocular pressure increase after phacoemulsification and the role of perioperative apraclonidine. J Cataract Refract Surg 28(12):2177–2180
Pharmakakis N, Giannopoulos K, Stasinos S, Makri OE, Georgakopoulos CD (2011) Effect of a fixed brimonidine–timolol combination on intraocular pressure after phacoemulsification. J Cataract Refract Surg 37(2):279–283
Kaback M, Scoper SV, Arzeno G, James EJ, Hua YS, Salem C et al (2008) Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%. Ophthalmology 115(10):1728–1734
Craven ER, Walters TR, Williams R, Chou C, Cheetham JK, Schiffman R (2005) Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension. J Ocul Pharmacol Ther 21(4):337–348
Khor WB, Perera S, Jap A, Ho CL, Hoh ST (2009) Anterior segment imaging in the management of postoperative fibrin pupillary-block glaucoma. J Cataract Refract Surg 35(7):1307–1312
Yaylalı V, Özbay D, Tatlıpınar S, Yıldırım C, Özden S (2004) Efficacy and safety of rimexolone 1% versus prednisolone acetate 1% in the control of postoperative inflammation following phacoemulsification cataract surgery. Int Ophthalmol 25(1):65–68
Tranos P, Bhar G, Little B (2004) Postoperative intraocular pressure spikes: the need to treat. Eye (Lond) 18(7):673–679
Zamvar U, Dhillon B (2005) Postoperative IOP prophylaxis practice following uncomplicated cataract surgery: a UK-wide consultant survey. BMC Ophthalmol 5:24
Konstas AGP, Holló G, Haidich A-B, Mikropoulos DG, Giannopoulos T, Voudouragkaki IC et al (2013) Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy. J Ocul Pharmacol Ther 29(7):652–657
Cheng JW, Cheng SW, Gao LD, Lu GC, Wei RL (2012) Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis. PLoS ONE 7(9):1–11
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership or other equity interest; and expert testimony or patent–licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Balsak, S., Kaydu, A., Erdem, S. et al. Brimonidine–timolol versus brinzolamide–timolol for treatment of elevated intraocular pressure after phacoemulsification surgery. Int Ophthalmol 38, 1583–1589 (2018). https://doi.org/10.1007/s10792-017-0626-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-017-0626-z